logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
02/09/2025
Ding Pharmaceutical announced that its product, TIVDAK, has been approved for use in Hong Kong for patients with recurrent or metastatic cervical cancer.
Latest
1 m ago
Institution: BYD's car sales growth rate may slow down this year.
1 m ago
Morningstar analyst Vincent Sun wrote in a report that the growth rate of BYD's car sales will slow down this year, due to a higher base effect compared to last year and a lack of attractive new car models in a competitive market. He added that the company's net profit in the second quarter was lower than Morningstar's expectations. He also mentioned that despite an increase in car sales, a rise in export contributions, and a decrease in battery costs, BYD's aggressive price promotions have increased pressure on the profit margin of this electric car manufacturer. Morningstar has lowered its 2025 car sales forecast for the company by 7% to account for the sales trends so far this year, and has also lowered its revenue forecast for this year by 4%. Due to concerns about competition and price pressure, the analyst has also lowered the car profit margin expectations.
3 m ago
According to AI Express News, Huatai Securities issued a research report on September 2, giving a buy rating to Yangnong Chemical (600486.SH). The rating reasons mainly include: 1) the prices of some products are expected to rebound in the second quarter of 2025, and pesticides are expected to come out of the bottom range; 2) there are signs of stabilization in the agricultural chemical industry, waiting for the industry to recover; 3) the Huludao project is advancing rapidly, opening up profit space for counter-cyclical expansion. (Daily Economic News)
3 m ago
According to EachEnterprise AI News, Great Wall Guorui Securities released a research report on September 1, giving a "buy" rating to PureSi (301257.SZ). The rating reasons mainly include: 1) improving performance marginally, restoring profitability; 2) continuous recovery in industry demand, rapid growth in new signed orders, with nearly 2 billion yuan in hand orders. (Daily Economic News)
4 m ago
Zhejiang Jiaoke (002061.SZ) received the winning notice for the relevant expressway project of its subsidiary company.
See all latestmore
logo
Contact US
qr
+852 - 60190728
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.